tiprankstipranks
TScan Therapeutics (TCRX)
NASDAQ:TCRX
US Market

TScan Therapeutics (TCRX) Technical Analysis

158 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
5Neutral
6Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
TScan Therapeutics’s (TCRX) Moving Averages Convergence Divergence (MACD) indicator is -0.46, suggesting TScan Therapeutics is a Sell.
TScan Therapeutics’s (TCRX) 20-Day exponential moving average is 6.63, while TScan Therapeutics’s (TCRX) share price is $7.1, making it a Buy.
TScan Therapeutics’s (TCRX) 50-Day exponential moving average is 7.21, while TScan Therapeutics’s (TCRX) share price is $7.1, making it a Sell.

TScan Therapeutics (TCRX) Pivot Points

Jul 19, 2024, 09:25 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.66
5.91
6.37
6.62
7.08
7.33
7.79
Fibonacci
5.91
6.18
6.35
6.62
6.89
7.06
7.33
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

TScan Therapeutics (TCRX) Moving Averages

Jul 19, 2024, 09:25 AM
Period
Simple
Exponential
MA5
6.28Buy
6.41Buy
MA10
6.05Buy
6.32Buy
MA20
6.56Buy
6.63Buy
MA50
7.79Sell
7.21Sell
MA100
7.50Sell
7.07Sell
MA200
6.17Buy
5.92Buy
TScan Therapeutics’s (TCRX) 10-Day exponential moving average is 6.32, while TScan Therapeutics’s (TCRX) share price is $7.1, making it a Buy.
TScan Therapeutics’s (TCRX) 100-Day exponential moving average is 7.07, while TScan Therapeutics’s (TCRX) share price is $7.1, making it a Sell.
TScan Therapeutics’s (TCRX) stock price is $7.1 and TScan Therapeutics’s (TCRX) 50-day simple moving average is 7.79, creating a Sell signal.
TScan Therapeutics’s (TCRX) stock price is $7.1 and TScan Therapeutics’s (TCRX) 100-day simple moving average is 7.50, creating a Sell signal.
TScan Therapeutics’s (TCRX) stock price is $7.1 and TScan Therapeutics’s (TCRX) 200-day simple moving average is 6.17, creating a Buy signal.

TScan Therapeutics (TCRX) Technical Indicators

Jul 19, 2024, 09:25 AM
Name
Value
Implied Action
RSI (14)
48.48
Neutral
STOCH (9,6)
80.24
Sell
STOCHRSI (14)
66.09
Neutral
MACD (12,26)
-0.46
Sell
ADX (14)
29.46
Neutral
Williams %R
-23.53
Buy
CCI (14)
20.11
Neutral
ATR (14)
0.60
-
Ultimate Oscillator
58.00
Neutral
ROC
3.69
Buy
TScan Therapeutics’s (TCRX) Relative Strength Index (RSI) is 48.48, creating a Neutral signal.
TScan Therapeutics’s (TCRX) Trend Strength Indicator (ADX) is 29.46, creating a Neutral signal.
TScan Therapeutics’s (TCRX) Commodity Channel Index (CCI) is 20.11, creating a Neutral signal.
TScan Therapeutics’s (TCRX) Price Rate of Change (ROC) is 3.69, creating a Buy signal.

FAQ

Is TCRX a Buy, Hold, or Sell?
Based on TCRX’s technical indicators, TCRX is a Buy.
    What is TCRX’s RSI (14)?
    TCRX’s RSI (14) is 48.48, which suggests TCRX is a Neutral.
      What is TCRX’s MACD?
      TCRX’s MACD is -0.46, which suggests TCRX is a Sell.
        What is TCRX’s 5-day moving average?
        TCRX’s 5-day moving average is 6.28, which suggests TCRX is a Buy.
          What is TCRX’s 20-day moving average?
          TCRX 20-day moving average is 6.56, which suggests TCRX is a Buy.
            What is TCRX’s 50-day moving average?
            TCRX’s 50-day moving average is 7.79, which suggests TCRX is a Sell.
              What is TCRX’s 200-day moving average?
              TCRX’s 200-day moving average is 6.17, which suggests TCRX is a Buy.
                What is TCRX’s Williams % R (14)?
                TCRX’s Williams % R (14) is -23.53, which suggests TCRX is a Buy.
                  What is TCRX’s CCI (14)?
                  TCRX’s CCI (14) is 20.11, which suggests TCRX is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis